Consolidation of independent practices is a problem and it's being fueled by the 340B program. It's why transparency is needed. @CSROAdvocacy's Dr. Erin Arnold on @ramblin_ray @wlsam890 on how misuse of the program impacts community-based care in Illinois. https://bit.ly/4sZZm71

Op-Ed: Critical infusion therapies are at risk for New Jerseyans. Congress can change that Understand the importance of infusion therapies for chronic conditions and the potential impact of new Medicare policies.

Infusion centers provide essential, community-based care. Lawmakers should advance #PACTA and protect community-based infusion services patients rely on. @SenatorAndyKim @SenBooker @RepHerbConaway @Congressman_JVD @DonaldNorcross bit.ly/3PN8bCs

A drug affordability board would hurt Illinois patients | Opinion An Illinois physician says that proposed drug affordability legislation could do more harm than good for patients.

"When a board of unelected officials sets reimbursement limitations, infusion centers like mine face a difficult choice: absorb the loss or send our patients elsewhere for treatment." Read more from Illinois provider Dr. Dareen Siri in @SJRbreaking: https://bit.ly/4topYhA

Big advocacy win in Virginia! Governor Spanberger just signed into law major PBM reforms that include “de-linking” and “rebate pass-through” provisions to help lower costs for patients statewide. Thank you @SpanbergerForVA!

We joined GCOA and nearly 30 other patient advocacy groups in urging @GovernorVA Spanberger to protect access to lifesaving treatments for Virginians and VETO legislation that would import federal MFPs to the Commonwealth. https://bit.ly/4uAl4Q4

Congress must pass this law to protect NJ patients' access | Opinion The Protecting Patient Access to Cancer and Complex Therapies Act -- PACTA -- is critical to NJ patients who need access to infusion therapies.

"Policies that steer patients away from accessible, community-based care and into higher-cost settings should be off the table.”

Read more from FloMed Infusion's Batsheva Weisz in @northjersey: bit.ly/40HciCa #PACTA

Infusion providers & clinicians: your voice matters in Medicare drug price talks

CMS is hosting public engagement events—clinicians, patients, & caregivers can share experiences on access, affordability & real-world outcomes.

Register: March 2026
Events: April 2026

Learn more: go.cms.gov/4cmqqI1

Landmark PBM reforms have been signed into law, a major win for infusion providers. Medicare Part D delinking, commercial rebate pass-through, and a ban on Medicaid spread pricing will help increase transparency and affordability.

ALERT: CMS selects 15 drugs for 3rd cycle of Medicare price negotiations, including first Part B drugs. Prices take effect 2028. Check out CMS' fact sheet here: www.cms.gov/files/docume...

National Infusion Center Association National Infusion Center Association

This week, the Senate will vote on commonsense PBM reforms that support provider infusion center sustainability and protect patient access to care.

Call your Senators and urge their support. nica.quorum.us/campaign/153...

Thank you to @SenShaneReeves for introducing SB 1796, a bill that strengthens transparency and accountability for PBMs in Tennessee. Public reporting of PBM violations is a critical step toward fair practices and patient protection.

NICA appreciates @HouseCommerce and @WaysandMeansGOP for examining rising health care costs today. Insurers must be held accountable for practices that block patients from timely, high-quality infusion care.

National Infusion Center Association National Infusion Center Association

ALERT: CA anti-steering bill AB 577 will be heard in Assembly Appropriations tomorrow (Jan 22). AB 577 would stop insurers from forcing patients to use specific providers or self-administer meds when provider-administered care is medically necessary. Take action: bit.ly/4r6opnz

Alert: MO All Copays Count bill SB970 will be heard tomorrow (1/14) in the MO Families, Seniors & Health Committee. The legislation helps protect access to infusion care by ensuring payments count toward patient deductibles and out-of-pocket limits. Take action, send a support letter: bit.ly/3NicVia

National Infusion Center Association National Infusion Center Association

NH Senate Health and Human Services Committee considers SB 547 on Wed, Jan 14. This bill takes on PBMs driving up drug costs by ending spread pricing, requiring transparency, and putting patients first.

Take action in support of SB 547 today!

bit.ly/3Nk51EX

Thank you @PhilMurphy for enacting A5217 to protect access to infusion care in NJ. Applying third-party assistance to patient cost sharing reduces treatment disruptions & supports timely, affordable care. NJ now joins majority states, plus DC & Puerto Rico, with All Copays Count laws in place.

Alert: 2026 Medicare Provider Enrollment Updates Infusion Centers Should Know About | National Infusion Center Association Tucked away in the Centers for Medicare and Medicaid Services (CMS) CY 2026 Home Health and DMEPOS final rule, CMS finalized several updates to Medicare provider […]

Medicare Enrollment Rules Are Changing in 2026
CMS has finalized new rules that could affect Medicare billing, enrollment status, and provider reporting deadlines. Some changes give CMS authority to pause or revoke enrollment & shorten reporting timeframes
Learn More: bit.ly/4s4EMlQ

NICA applauds @KeanForCongress and @RepBarragan for reintroducing the HELP Copays Act to ensure copay assistance actually counts toward patients’ cost-sharing. Insurers’ double-dipping must end.

A federal safety net program is leaving Ohio patients behind • Ohio Capital Journal The 340B Drug Pricing Program is supposed to save hospitals money on drugs to serve low-income and uninsured patients, but Ohio's largest health systems are running away with the savings as profits, i...

The #340B program was meant to be a safety net -- not a profit center for large hospitals.

Read more from a new opinion by NICA member Keith Hostetler of Pace Healthcare in @OhioCapJournal on how the program is leaving patients behind in Ohio: bit.ly/4qhiWus

Federal drug pricing proposal will cost NC patients their care Most Favored Nation policy may sound like a way to save money. But in reality, many community clinics and infusion centers would no longer afford to operate.

Our health care system needs reform, but MFN gets it wrong. Instead of targeting middlemen driving up costs, it harms the sites of care that keep treatment affordable & accessible. Read why NICA member Constance Moscati says policymakers should reject MFN: bit.ly/4ocwCoQ

National Infusion Center Association Statement on Colorado PDAB’s Upper PaymentLimit for Enbrel | National Infusion Center Association FOR IMMEDIATE RELEASE The National Infusion Center Association (NICA) expresses deep concern over the Colorado Prescription Drug Affordability Board’s (PDAB) decision to impose an upper payment […]

NICA is deeply concerned by Colorado PDAB’s decision to set an upper payment limit for Enbrel based on the Medicare MFP. This untested model risks reduced access to essential therapies and added burdens for patients and providers. Read our statement here: infusioncenter.org/national-inf...

Don’t Let Middlemen Off the Hook in the Drug Pricing Debate – DC Journal - InsideSources President Trump’s recent directive to 17 pharmaceutical manufacturers demanding that U.S. drug prices align with the lowest prices in other developed

Let's talk about the real cause of high drug costs. The president’s most-favored-nation pricing model ignores the unchecked power of pharmacy benefit managers (PBMs). It's time to hold them accountable. dcjournal.com/dont-let-mid...

#NICA #InfusionCenters

EACH/PIC Releases Results from Patient-Led Survey on Drug Affordability | EACH/PIC Coalition Patient-Led Survey Reveals Insurance Barriers and Personal Factors Contribute Significantly to Patient Affordability Concerns

What do patients really think about drug costs?
New survey from @eachpic finds affordability is often about access and insurance policies

Learn more: eachpic.org/each-pic-rel...

#DrugAffordability #PatientsFirst

EACH/PIC Releases Results from Patient-Led Survey on Drug Affordability | EACH/PIC Coalition Patient-Led Survey Reveals Insurance Barriers and Personal Factors Contribute Significantly to Patient Affordability Concerns

New from the EACH/PIC Coalition: Initial findings from the Patient Experience Survey reveal that “unaffordability” is about more than cost. Patients face complex barriers tied to coverage, access, and system design.

Read the full report eachpic.org/each-pic-rel...

Thank you @RepGregMurphy, @RepAdamGrayCA, and @DrNealDunnFL2 for reintroducing the Protecting Patient Access to Cancer and Complex Therapies Act! Ensuring fair reimbursement for infusion providers is essential to safeguarding patient access to life-saving, provider-administered treatments.

UPDATE: President Trump signs One Big Beautiful Bill Act on July 4th
• One-year 2.5% Medicare physician payment increase (2026)
• Medicaid work reqs + 3.5% cap on provider taxes in expansion states (CBO: 11.8M more uninsured by 2034)
• An expansion to the orphan drug exemption under the MDPNP

Thank you, Gov. Kelly Ayotte, for protecting access to life-saving care by repealing policies that would have imposed harmful reimbursement cuts for NH infusion providers. Your leadership ensures patients with chronic, rare conditions can keep receiving the timely, high-quality treatment they need.

Great news for Nevada infusion providers: Nevada Gov. Joe Lombardo vetoed AB 259, which would’ve tied provider reimbursement to Medicare drug pricing. Thanks to the Governor for protecting provider sustainability & patient access. #InfusionCare #HealthcareVictory #Nevada

Thank you, @GovMurphy, for signing A1825 into law! A1825 helps patients get needed medications faster by allowing common-sense exceptions to step therapy (“fail-first”) protocols imposed by insurers. It puts decisions back where they belong, with patients and doctors. A Big win for New Jersey!

Vermont Infusion Patients, All Copays Count bill S 30 is up for consideration by the VT Senate Finance Committee TOMORROW! Help us show support by sending a letter to urge them to pass the bill.

Date: THUR, FEB 6
Time: 1:00 PM ET

Take action here: infusionaccessfoundation.quorum.us/campaign/109...